(Information sent by the signatory company)

TORRANCE, California, Feb. 1, 2024 /PRNewswire/ -- Phenomenex Inc., a global leader in the research and manufacturing of advanced separation sciences and technologies, proudly announces the appointment of Dr. Kaveh Kahen as president of the company.

Dr. Kahen returns to the Danaher Life Sciences platform with a wealth of experience. He began his career at SCIEX and was responsible for designing and developing novel technologies and instruments. He then assumed several leadership positions at PerkinElmer.

Most recently, Dr. Kahen was CEO of Advion Interchim Scientific. During his tenure, he successfully led the integration of US and European entities, resulting in consecutive years of above-market growth. Kaveh is known for driving profitable growth in the highly competitive life sciences, analytical testing and laboratory equipment markets.

Expressing his commitment, Dr. Kahen commented, "I am honored to join a company revered for its innovation, dedication and excellence in the world of chromatography and analytical sciences."

"As President, I can reaffirm that our focus remains strong on delivering innovative solutions and unmatched service to our partners and customers in the life sciences sector."

Dr. Kahen has a PhD in Analytical Chemistry from George Washington University. He succeeds Matt Turner, who has decided to explore other opportunities.

For more information, visit www.phenomenex.com and follow the company's blog at www.scienceunfiltered.com

About Phenomenex Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in academic, pharmaceutical, biotechnology, environmental, clinical research, government and industrial laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve human health and well-being. Phenomenex is an operating company within the life sciences group of Danaher Corporation.

Let's connect: LinkedIn, Twitter, Facebook, Instagram and YouTube

Photo - https://mma.prnewswire.com/media/2331803...Logo - https://mma.prnewswire.com/media/2157889...

View original content: https://www.prnewswire.com/news-releases/el-doctor-kaveh-kahen-presidente-designado-de-phenomenex-302050317.html